Research and development - Press Releases

Date	Title	Company
16-Sep-2022	Ovation Science Strengthens IP Protection with New US Patent	Ovation Science Inc.
16-Sep-2022	Alfa Chemistry Offers High-Quality Dexmedetomidine Hydrochloride Meeting CP & EP Standards	Alfa Chemistry
16-Sep-2022	New Study Reveals First Genetic Links in ME and Chronic Fatigue Syndrome Paving the Way for New Diagnostics and Drugs	PrecisionLife
13-Sep-2022	The Medicines Patent Pool and MedinCell sign licence agreement for mdc-STM, an investigational long-acting injectable formulation to fight malaria transmission	The Medicines Patent Pool
13-Sep-2022	MGI Kicks Off ICG-17 in Riga with Launch of DNBSEQ-T7** HotMPS High-Throughput Sequencing Kit* and Spatial Transcriptomics Grant Program	MGI Tech Co. Ltd
13-Sep-2022	midge medical GmbH has received a CE-IVD mark for its SARS-CoV-2 PoC-NAT professional use “minoo” rapid testing system	midge medical GmbH
13-Sep-2022	AccuStem Sciences Announces Issuance of US Patent for StemPrintER Test for Patients with Breast Cancer	AccuStem
13-Sep-2022	BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency	BD
13-Sep-2022	Nature Inspired Peptide Has Anti-Tumor-Activity	Karl Landsteiner University of Health Sciences
13-Sep-2022	MGI Kicks Off ICG-17 in Riga with Launch of DNBSEQ-T7** HotMPS High-Throughput Sequencing Kit* and Spatial Transcriptomics Grant Program	MGI
13-Sep-2022	SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis	SiSaf
13-Sep-2022	ISCT issues response to US federal judge ruling on FDA regulation of cell and gene therapies	ISCT
13-Sep-2022	Alfa Chemistry Newly Releases Biological Stains for Laboratory and Diagnostic Use	Alfa Chemistry
13-Sep-2022	CD Formulation: Accelerated Shelf-Life Testing to Assess Drug Stability	CD Formulation
12-Sep-2022	SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis	SiSaf
12-Sep-2022	TMA Precision Health and Dante Genomics partner to help children with rare diseases through clinical whole genome sequencing solutions	Dante Genomics
12-Sep-2022	ISCT addresses manufacturing standardization, a critical issue constraining the CGT development pipeline	ISCT
11-Sep-2022	Blood Clot Retrieval Devices Market Size Will Achieve USD 5.6 Billion By 2030 Growing At 18.4% CAGR - Exclusive Report by Acumen Research and Consulting	Acumen Research And Consulting
11-Sep-2022	Behavioral Health Market Size To Gain USD 267 Billion Revenue By 2030 Growing At 2.5% CAGR – According To A Report By Acumen Research And Consulting	Acumen Research And Consulting
11-Sep-2022	Hypertension Drugs Market Size To Gain USD 34,072 Million Revenue By 2030 At 3.4% CAGR During 2022 to 2030	Acumen Research And Consulting